Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus

We compared the effect of dapagliflozin versus glibenclamide on the ratio of lean-to total mass in patients with type 2 diabetes mellitus, carotid subclinical atherosclerosis, HbA1c 7.0–9.0% and 40–70 years-old. Ninety-eight patients (61% male; mean age 57 ± 7 years) were randomized into dapaglifloz...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Vaneza Lira W., Breder, Ikaro, de Carvalho, Luiz Sérgio F., Soares, Alexandre A. S., Cintra, Riobaldo M., Barreto, Joaquim, Munhoz, Daniel B., Kimura-Medorima, Sheila T., Nadruz, Wilson, Guerra-Júnior, Gil, Quinaglia, Thiago, Muscelli, Elza, Sposito, Andrei C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197757/
https://www.ncbi.nlm.nih.gov/pubmed/34120150
http://dx.doi.org/10.1038/s41387-021-00160-5

Ejemplares similares

Ejemplares similares